SG11201500632VA - Anti-viral methods and the use of an anti-viral agent - Google Patents

Anti-viral methods and the use of an anti-viral agent

Info

Publication number
SG11201500632VA
SG11201500632VA SG11201500632VA SG11201500632VA SG11201500632VA SG 11201500632V A SG11201500632V A SG 11201500632VA SG 11201500632V A SG11201500632V A SG 11201500632VA SG 11201500632V A SG11201500632V A SG 11201500632VA SG 11201500632V A SG11201500632V A SG 11201500632VA
Authority
SG
Singapore
Prior art keywords
viral
methods
agent
viral agent
viral methods
Prior art date
Application number
SG11201500632VA
Inventor
Ho Sup Yoon
Ding Xiang Liu
Quoc Toan Nguyen
Original Assignee
Univ Nanyang Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nanyang Tech filed Critical Univ Nanyang Tech
Publication of SG11201500632VA publication Critical patent/SG11201500632VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201500632VA 2012-08-14 2013-08-05 Anti-viral methods and the use of an anti-viral agent SG11201500632VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261682932P 2012-08-14 2012-08-14
PCT/SG2013/000329 WO2014027958A1 (en) 2012-08-14 2013-08-05 Anti-viral methods and the use of an anti-viral agent

Publications (1)

Publication Number Publication Date
SG11201500632VA true SG11201500632VA (en) 2015-02-27

Family

ID=50101349

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201701154RA SG10201701154RA (en) 2012-08-14 2013-08-05 Anti-viral methods and the use of an anti-viral agent
SG11201500632VA SG11201500632VA (en) 2012-08-14 2013-08-05 Anti-viral methods and the use of an anti-viral agent

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201701154RA SG10201701154RA (en) 2012-08-14 2013-08-05 Anti-viral methods and the use of an anti-viral agent

Country Status (4)

Country Link
KR (1) KR102257437B1 (en)
BR (1) BR112015003353A2 (en)
SG (2) SG10201701154RA (en)
WO (1) WO2014027958A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102007096B1 (en) * 2017-12-18 2019-08-02 경희대학교 산학협력단 Composition for preventing or treating hearing loss comprising Viscum ovalifolium extracts
US20220339241A1 (en) 2019-07-09 2022-10-27 Unichem Laboratories Ltd Stable formulations of recombinant proteins
CN113350482B (en) * 2021-05-31 2022-05-27 中国食品药品检定研究院 Application of phytohemagglutinin PHA-E in preparation of medicine for treating diseases caused by coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565200A (en) * 1995-04-14 1996-10-15 University Of Southern California Pharmaceutical preparations derived from korean mistletoe
KR101012507B1 (en) * 2008-01-08 2011-02-08 (주)디딤바이오텍 A composition for sanitary supplies comprising mucosal immunoadjuvant and a preparation method thereof
DE102011003478A1 (en) * 2011-02-01 2012-08-02 Cytavis Biopharma Gmbh Antiviral agent containing recombinant mistletoe lectins

Also Published As

Publication number Publication date
KR102257437B1 (en) 2021-05-31
KR20150042852A (en) 2015-04-21
BR112015003353A2 (en) 2017-12-05
WO2014027958A1 (en) 2014-02-20
SG10201701154RA (en) 2017-04-27

Similar Documents

Publication Publication Date Title
HK1208439A1 (en) 5-azaindazole compounds and methods of use 5-
IL235536A0 (en) Metamaterial devices and methods of using the same
HK1203493A1 (en) Substituted azabicycles and use thereof
EP2912178A4 (en) Super-enhancers and methods of use thereof
EP2828258A4 (en) Novelpyridopyrimidine derivatives and use thereof
ZA201500698B (en) Hydroxamate substituted azaindoline-cyanine dyes and bioconjugates of the same
EP2834421A4 (en) Stabilizing agents and methods of use thereof
HUE042637T2 (en) Laminates and methods of making the same
HK1221416A1 (en) Formulations of oxabicycloheptanes and oxabicycloheptenes
IL240248A0 (en) Met-binding agents and uses thereof
GB201301626D0 (en) Composition comprising 15-OHEPA and methods of using the same
IL234756A0 (en) Immunomodulatory agent and uses therefor
GB201216649D0 (en) Agents and methods
EP2852397A4 (en) Huwentoxin-iv variants and methods of use
HK1203198A1 (en) Substituted phenylimidazopyrazoles and use thereof
HK1198833A1 (en) N-acylpeptide derivatives and their uses n-
HK1210809A1 (en) Beta-hexosyl-transferases and uses thereof
EP2909285A4 (en) Gelling agents and methods of using the same
EP2906576A4 (en) Glycosphingolipids and methods of use thereof
SG10201701154RA (en) Anti-viral methods and the use of an anti-viral agent
HK1202853A1 (en) Thixotropic agents and methods of use
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
GB201305297D0 (en) Novel agents and uses thereof
EP2834635A4 (en) Heparin-bulking agent compositions and methods thereof
HK1207154A1 (en) C1q-adiponectin complex and use thereof c1q-